Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

TGA Regulations on Breast Implant Products

September 30, 2019 By Law Offices of Thomas J. Lamb, P.A.

Implants in Australia

Back in July, health officials in Australia recommended the ban of textured implants.  Our previous July 2019 article, “Textured Breast Implants Ban: Onto Australia“, discussed the type of implants up for suspension by Australia’s Therapeutic Goods Administration (TGA).

Now in Australia, textured breast implants being sold there are under regulation due to the risk of BIA-ALCL. This recall and ban includes eight types of “macro” and “micro” textured implants. The Medtechdive article, “Australia enforces new regs on all breast implant makers, suspends some devices“, discusses what led to the regulations:

The regulator’s review took into account input from manufacturers, patients and the Breast Implant Working Group, a cohort of experts TGA convened in April after regulators in France and Canada took action against textured implants. The review involved lab testing of implant samples as well as a “full statistical review” of all BIA-ALCL cases reported through the end of May.

The TGA said all implants and tissue expanders will be banned for the next 6 weeks until concerns are addressed and fixed.

 

Regulations and Statistics

Here are the regulations being placed on breast implant manufacturers and sponsors:

Implant sponsors must report all cases of BIA-ALCL to the TGA within 10 working days and provide six-monthly reports of Australian and worldwide supply, complaints and adverse events data.

Manufacturers must also provide doctors and patients with clear, written information about the risk of BIA-ALCL, which is very rare.

According to the Sydney Morning Herald article,” ‘Significant jump’ in cancer linked to breast implants as ban decision looms“,  73.9 percent of the 700 confirmed cases of BIA-ALCL were in connection with the highest textured implants, grade 4 and grade 3. Getting ALCL was 1 in 2800 for grade 4 implants and 1 in 3300 for grade 3 implants. Grade 2 implants were the least concerning, only being 19.6 percent of the 700 cases and with a risk of 1 in 84,000.

 

Australia’s TGA and United States’ FDA

Our July 2019 article referenced another article by the Sydney Morning Herald, “Breast Implant Ban, Recall Proposed by TGA“, which provided a chart of the sixteen implants under proposed suspension.  Of those sixteen, seven manufacturers also appear in the United States.  The eight textured implants that are being recalled and banned in Australia right now are not ones that are also in the U.S.

From the Medtechdive article, we can also learn that the FDA may be placing more regulations on products manufactured in the United States, “At a two-day advisory committee meeting on the subject in March, stakeholders discussed the possibility of adding a black box warning and a more thorough informed consent checklist to the devices”.

We are glad to see the positive step that the TGA is making as regards breast implants and emphasizing the seriousness of the risks.  We will continue to provide updates as we learn more information about any decisions to recall or ban implants.

 

We encourage you to visit our Breast Implants Lymphoma Cancer page on our website for more information and submit a free case evaluation if you or someone you know has been diagnosed with BIA-ALCL.

 

Written by: Laura Beasley, Legal Assistant

Law Offices of Thomas J. Lamb, P.A.

 

Breast Implants: Lymphoma / Blood Cancer Cases Overview

Free Breast Implants Case Evaluation

 

 

Filed Under: Unsafe Medical Devices Tagged With: breast implants, breast implants BIA-ALCL, textured breast implants

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.